"A small leak will sink a great ship": hypoxia-inducible factor and group III pulmonary hypertension.

Receptors Clin Investig

Department of Molecular Genetics & Microbiology, University of Florida College of Medicine, Gainesville, FL 32610-0225, USA.

Published: March 2016

Pulmonary hypertension complicating idiopathic pulmonary fibrosis, also known as secondary pulmonary hypertension, represents a major source of morbidity and mortality in affected patients. While the study of primary pulmonary arterial hypertension has yielded several therapies, the same is not true for the treatment of pulmonary hypertension secondary to pulmonary fibrosis. Recent studies have indicated an important role of hypoxia-inducible factor (HIF) - a regulatory protein that is vital in adaptation to hypoxic conditions - in the development of secondary pulmonary hypertension. HIF influences development of hypoxia-induced pulmonary hypertension through alteration in voltage-gated potassium channels and homeostatic calcium regulation, resulting in disruption of endothelial cell-cell communication, and eventual vascular remodeling. This article summarizes salient literature related to HIF and secondary pulmonary hypertension, in addition to proposing a final common pathway in known mechanistic pathways that result in endothelial barrier integrity loss - vascular "leak" - primarily through a shared endothelial-epithelial signaling protein family, CCN.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950984PMC
http://dx.doi.org/10.14800/rci.1213DOI Listing

Publication Analysis

Top Keywords

pulmonary hypertension
28
secondary pulmonary
16
pulmonary
10
hypoxia-inducible factor
8
hypertension
8
pulmonary fibrosis
8
small leak
4
leak will
4
will sink
4
sink great
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!